Hermetica Superfood Encyclopedia
The Short Answer
Boesenbergia rotunda contains approximately 205 characterized metabolites, with the chalcone panduratin A as its principal bioactive compound, exerting antiviral, anti-inflammatory, and anticancer effects through NF-κB pathway inhibition, caspase activation, and direct viral protease interference. Panduratin A demonstrated anti-SARS-CoV-2 activity with an IC₅₀ of 0.81 µM in vitro—a potency comparable to remdesivir (IC₅₀ 2.71 µM)—while cardamonin induces G2/M-phase cell cycle arrest and caspase-dependent apoptosis in nasopharyngeal carcinoma cell lines.
CategoryRoot
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordBoesenbergia rotunda benefits
Fingerroot — botanical close-up
Health Benefits
**Antiviral Activity**
Panduratin A inhibits SARS-CoV-2 replication in vitro with an IC₅₀ of 0.81 µM, a potency exceeding remdesivir (IC₅₀ 2.71 µM), likely through interference with viral proteases and host cell entry mechanisms; this positions it as a candidate scaffold for antiviral drug development.
**Anti-inflammatory Effects**
Multiple flavonoids including pinostrobin and alpinetin suppress NF-κB signaling and downstream pro-inflammatory cytokine production, providing mechanistic support for the herb's long-standing traditional use in managing inflammatory digestive and musculoskeletal conditions in Thai folk medicine.
**Anticancer Potential**
Cardamonin induces caspase-dependent apoptosis and arrests cells in the G2/M phase in nasopharyngeal carcinoma models; panduratin A demonstrated an IC₅₀ of 4.4 µg/mL against A549 human non-small cell lung cancer cells in preclinical in vitro assays.
**Antimicrobial Properties**
Ethanol extracts exhibit rapid bactericidal activity against Streptococcus mutans within 2 minutes at 50 µg/mL, with minimum inhibitory concentrations (MIC) of 0.5 µg/mL against both Escherichia coli and Staphylococcus aureus, suggesting broad-spectrum antimicrobial utility.
**Antioxidant Capacity**
Phenolic flavonoids including pinocembrin and cardamonin scavenge free radicals with antioxidant IC₅₀ values ranging from 46.66 to 62.84 µg/mL for isolated compounds, and 92.64 µg/mL for crude ethanol extracts, contributing to cellular cytoprotection.
**Bone Health Support**
Flavonoid fractions stimulate osteoblastogenesis, with alkaline phosphatase (ALP) activity—a marker of osteoblast differentiation—observed at treatment concentrations of 50 µg/mL in cell culture systems, suggesting a potential role in supporting bone mineral density.
**Digestive Health**
Traditional Thai and Malaysian medicine employs the rhizome to relieve flatulence, nausea, and gastrointestinal cramping; preclinical data on smooth muscle relaxation and anti-spasmodic effects of its chalcone and flavanone constituents provide partial mechanistic corroboration.
Origin & History
Natural habitat
Boesenbergia rotunda is native to South and Southeast Asia, with primary cultivation across Thailand, Malaysia, Indonesia, and southern China, where it thrives in humid tropical forest understories and well-drained, loamy soils. The plant is a perennial rhizomatous herb of the Zingiberaceae family, growing 30–60 cm in height with finger-like lateral rhizomes that give rise to its common name 'fingerroot.' It has been cultivated both as a culinary spice—integral to Thai and Indonesian cuisine—and as a medicinal herb for centuries, with wild populations also harvested from forest margins throughout the Mekong basin region.
“Boesenbergia rotunda has been integral to the culinary and medicinal traditions of Thailand, Malaysia, and Indonesia for at least several centuries, appearing in ancient Thai herbal pharmacopoeias under the name 'krachai' and in Malay traditional medicine as 'temu kunci.' Thai folk medicine employs the rhizome as a digestive carminative, anti-flatulent, and remedy for oral ulcers and dysentery, with preparations ranging from raw consumption to rhizome decoctions and topical poultices for skin conditions. In Indonesian jamu—the traditional herbal medicine system—B. rotunda features in compound formulas targeting fatigue, sexual vitality, and urinary disorders, reflecting a broad ethnopharmacological profile. The plant also holds cultural significance as a culinary herb in green curry pastes and fermented fish dishes throughout the Mekong region, blurring the boundary between food and medicine in a manner consistent with the Southeast Asian concept of 'functional food.'”Traditional Medicine
Scientific Research
The evidence base for B. rotunda consists entirely of in vitro cell culture studies and in vivo animal experiments; no peer-reviewed human clinical trials have been published as of the available literature. Preclinical studies have characterized 205 metabolites, with antiviral IC₅₀ values, anticancer cell-line data, and MIC values derived from controlled laboratory assays rather than randomized controlled trials, meaning direct translation to human dosing and efficacy remains unvalidated. Encapsulation research using maltodextrin and gum arabic wall materials has demonstrated improved compound stability and bioavailability in model systems, with total phenolic content ranging from 8.3 to 11.5 mg GAE/g in encapsulated preparations, but clinical pharmacokinetic data in humans are absent. The overall evidence level is preclinical-only, and while the breadth of characterized bioactive compounds and diversity of demonstrated mechanisms are scientifically noteworthy, regulatory-grade efficacy and safety claims cannot be supported by the current literature.
Preparation & Dosage
Traditional preparation
**Fresh Rhizome (Culinary)**
5–15 g per dish as a spice and flavoring; no therapeutic dose established from this form
Used in Thai cuisine at .
**Ethanol Extract (Research Grade)**
In vitro studies have used concentrations of 10–80 µg/mL in cell culture, but these do not translate directly to oral human doses without pharmacokinetic bridging data.
**Encapsulated Powder (Experimental)**
Formulations using maltodextrin and gum arabic as wall materials have been studied to improve stability; no commercial standardized supplement dose has been established or validated in humans.
**Isolated Panduratin A**
Demonstrates antiviral activity at 0.81 µM (approximately 0.33 µg/mL) in vitro; no oral bioavailability or human equivalent dose is currently characterized.
**Traditional Decoction**
10–30 g dried root per liter of water, though this has not been pharmacologically standardized
Rhizomes are boiled in water and consumed orally in Thai and Malaysian folk medicine for digestive complaints; typical traditional preparation uses .
**Standardization**
5 mg GAE/g has been reported for encapsulated forms in research settings
No internationally recognized standardization for panduratin A content in commercial preparations exists; total phenolic content of 8.3–11..
**Timing Note**
No clinical evidence exists to guide dosing timing; traditional use is typically with meals for digestive indications.
Nutritional Profile
The rhizome of B. rotunda is not a significant source of macronutrients in supplemental doses, but contains a rich phytochemical matrix of approximately 205 characterized metabolites. The dominant phytochemical class is flavonoids (compounds 1–83), including chalcones (panduratin A, panduratin B), flavanones (pinostrobin, pinocembrin, alpinetin), and flavones (cardamonin), which collectively account for the majority of documented biological activity. Monoterpenes (compounds 84–126) contribute to the essential oil fraction and aroma profile, while alkaloids (127–156), phenols (170–177), amides (178–183), and diterpenoids (192–194) represent minor but biologically active constituent classes. Total phenolic content in encapsulated preparations has been measured at 8.3–11.5 mg gallic acid equivalents per gram of sample. Bioavailability of key compounds is limited by poor aqueous solubility and susceptibility to oxidative degradation, challenges that encapsulation with maltodextrin and gum arabic has been shown to partially mitigate in experimental models.
How It Works
Mechanism of Action
Panduratin A, the principal chalcone of B. rotunda, inhibits the NF-κB transcription factor pathway by preventing IκB phosphorylation and nuclear translocation of p65, thereby suppressing expression of pro-inflammatory genes including COX-2, TNF-α, and IL-6. In viral contexts, panduratin A is proposed to interact with the SARS-CoV-2 main protease (Mpro) and potentially the spike protein receptor-binding domain, disrupting viral replication machinery at submicromolar concentrations. Cardamonin activates intrinsic apoptotic cascades by upregulating Bax and downregulating Bcl-2 expression, triggering cytochrome c release and caspase-3/7 activation, while simultaneously inducing G2/M cell cycle arrest through inhibition of cyclin B1 and CDC2 kinase activity. The antioxidant effects are mediated by direct hydrogen-atom transfer and electron donation from the hydroxyl groups of pinocembrin and pinostrobin to reactive oxygen species, complemented by upregulation of endogenous antioxidant enzymes including superoxide dismutase and catalase.
Clinical Evidence
No human clinical trials evaluating B. rotunda or its isolated constituents for any therapeutic indication have been identified in the published literature. All outcome data originate from in vitro assays—including cancer cell viability, antiviral replication inhibition, and antimicrobial MIC determinations—and in vivo rodent studies. Effect sizes reported, such as panduratin A IC₅₀ of 0.81 µM against SARS-CoV-2 and 4.4 µg/mL against A549 lung cancer cells, are experimentally derived under controlled laboratory conditions and should not be extrapolated to clinical efficacy without bridging pharmacokinetic and dose-escalation studies in humans. Confidence in clinical benefit is therefore low, and the ingredient should be regarded as a promising research lead rather than a clinically validated therapeutic agent.
Safety & Interactions
Comprehensive human safety data for B. rotunda are not available in the published literature, as no clinical trials have been conducted; the current safety profile is inferred from in vitro cytotoxicity studies and traditional use history rather than systematic pharmacovigilance. Encapsulated formulations of B. rotunda have been shown to reduce cytotoxicity relative to non-encapsulated crude extracts in cell culture models, suggesting that delivery form may significantly influence the safety margin, but this has not been confirmed in human subjects. Potential drug interactions have not been characterized, though the potent NF-κB inhibitory and cytochrome P450-modulating properties common to related Zingiberaceae members suggest theoretical interactions with anticoagulants, immunosuppressants, and chemotherapeutic agents; co-administration with these drug classes should be avoided until interaction studies are completed. Use during pregnancy and lactation is not recommended due to the complete absence of safety data in these populations and the pharmacological activity of its bioactive constituents.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
FingerrootTemu kunci (Indonesian/Malay)Kaempferia rotundaBoesenbergia rotunda (L.) Mansf.Krachai (Thai)Fingerroot (Boesenbergia rotunda)Chinese gingerLesser galangal
Frequently Asked Questions
What is panduratin A and why is it significant in Boesenbergia rotunda?
Panduratin A is the principal chalcone-class flavonoid isolated from the rhizome of Boesenbergia rotunda and is considered its most pharmacologically potent bioactive compound. It has demonstrated anti-SARS-CoV-2 activity in vitro with an IC₅₀ of 0.81 µM—exceeding the potency of remdesivir (IC₅₀ 2.71 µM) in the same assay—and also exhibits anticancer activity against A549 non-small cell lung cancer cells at an IC₅₀ of 4.4 µg/mL, along with NF-κB-mediated anti-inflammatory effects.
Is there clinical trial evidence supporting Boesenbergia rotunda for human use?
As of the current literature, no published human clinical trials have evaluated B. rotunda or its isolated constituents for any therapeutic indication. All available efficacy data derive from in vitro cell culture experiments and in vivo animal studies, meaning that while the preclinical profile is scientifically compelling, translation to validated human dosing and efficacy has not yet been established. The ingredient should be considered a promising research candidate rather than a clinically proven supplement.
What is the recommended dose of fingerroot supplement?
No standardized therapeutic dose of B. rotunda has been established for human supplementation, as no clinical pharmacokinetic or dose-finding trials have been conducted. In vitro studies have used concentrations of 10–80 µg/mL in cell culture, which do not directly translate to oral doses, and traditional Thai medicine employs 10–30 g of dried rhizome per liter in decoction form for digestive use. Until human bioavailability and dose-escalation data are available, no evidence-based dosing recommendation can be made.
What are the anti-inflammatory mechanisms of Boesenbergia rotunda?
The anti-inflammatory activity of B. rotunda is primarily attributed to its flavonoid constituents—particularly pinostrobin, alpinetin, and cardamonin—which inhibit the NF-κB signaling pathway by preventing phosphorylation of IκB, thereby blocking nuclear translocation of the p65 subunit and suppressing transcription of pro-inflammatory mediators including COX-2, TNF-α, and IL-6. Panduratin A contributes additional anti-inflammatory effects through direct enzyme inhibition and modulation of arachidonic acid metabolism, providing mechanistic support for the herb's traditional use in inflammatory digestive and musculoskeletal conditions in Thai and Malaysian folk medicine.
Is fingerroot (Boesenbergia rotunda) safe to take as a supplement?
Comprehensive human safety data for B. rotunda are currently unavailable, as no clinical trials have assessed its adverse effect profile, drug interactions, or maximum safe dose in people. Encapsulated formulations have shown reduced cytotoxicity compared to crude extracts in cell culture studies, and the herb has a long history of culinary and traditional medicinal use in Southeast Asia without widely reported acute toxicity. However, due to the absence of systematic safety studies, B. rotunda supplements are not recommended during pregnancy or lactation, and caution is warranted in individuals taking anticoagulants, immunosuppressants, or chemotherapy agents.
Does fingerroot interact with antiviral medications like remdesivir or antiretroviral drugs?
While panduratin A from fingerroot shows in vitro antiviral potency exceeding remdesivir, direct drug interaction studies between fingerroot supplements and prescription antivirals have not been published. Because fingerroot contains multiple bioactive compounds that may affect cytochrome P450 enzymes and viral protease inhibition pathways, individuals taking antiretroviral or antiviral medications should consult a healthcare provider before supplementing. Concurrent use could theoretically potentiate antiviral effects or alter drug metabolism, requiring medical supervision.
How does fingerroot's antiviral potency compare to other herbal antiviral supplements?
Fingerroot's panduratin A demonstrates superior in vitro inhibition of SARS-CoV-2 replication (IC₅₀ 0.81 µM) compared to remdesivir (IC₅₀ 2.71 µM), making it one of the most potent natural compound leads identified to date. However, this represents laboratory efficacy and does not directly translate to human clinical outcomes, as bioavailability, metabolism, and in vivo effectiveness remain unstudied. Most other herbal antivirals lack similarly robust mechanistic data, positioning fingerroot as a promising research candidate rather than a proven alternative to conventional antivirals.
Who should avoid fingerroot supplementation based on its mechanisms of action?
Individuals with bleeding disorders or taking anticoagulants (warfarin, DOAC agents) should exercise caution, as flavonoids in fingerroot may have antiplatelet properties. Pregnant and nursing women should avoid fingerroot due to insufficient safety data and the presence of bioactive compounds affecting immune and inflammatory pathways during gestation. Those with estrogen-sensitive conditions (certain breast cancers, endometriosis) should consult a physician, as some flavonoid constituents exhibit weak estrogenic activity.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w fingerroot-boesenbergia-rotunda-l-mansf curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
